APN/CD13 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APN/CD13 inhibitor, covering 2009-01-19 to 2009-01-19. Get the full timeline:
Most recent: Clinical Trial Update: Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis [Phase 2]